Testing effectiveness (Phase 2)Study completedNCT06691113
What this trial is testing
A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti--IL-33 mAb) in Participants With Chronic Rhinosinusitis Without Nasal Polyps
Who this might be right for
Chronic Rhinosinusitis Without Nasal Polyps
Sanofi 66